Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?

International Urology and Nephrology

Volumn 44, Issue 4, 2012, Pages 1113-1120

  Fillo, Juraj ^a,b   Breza, Jan ^a   Levčíkova, Michaela ^a   Luha, Jan ^a   Vachulova, Anna ^a   Durdík, Štefan ^a   Labaš, Peter ^a  

^a Physics and Informatics   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Abdominal obesity; Erectile dysfunction; Metabolic syndrome; Testosterone deficiency syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; BODY FAT DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; HEALTH HAZARD; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATIENT ASSESSMENT; RISK FACTOR; SCREENING TEST; TESTOSTERONE BLOOD LEVEL;

EID: 84867898848     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0132-1     Document Type: Article

References (36)

1. Nicolsi A, Moreira ED Jr, Shirai M, Bin Mohd Tambi MI, Glasser DB (2003) Epidemiology of erectile dysfunction in four countries: cross-national study of prevalence and correlates of erectile dysfunction. Urology 61:201-206
2. Melman A, Gingel JC (1999) The epidemiology and pathophysiology of erectile dysfunction. J Urol 161:5-11
3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinley IB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151(1):54-61
4. Parazzini F, Menchini Fabris F, Bortolotti A, Calabro A, Chatenoud L, Colli E (2003) Frequency and determinant of erectile dysfunction in Italy. Eur Urol 37:43-49
5. Makhsida N, Shah J, Yan G, Fish H, Shabsigh R (2005) Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol 174:827-834
6. Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrinol Rev 26:833-876
7. Gooren LJ, Saad F (2006) Recent insight into androgen action on the anatomical and physiological substrate of penile erection. Asian J Androl 8:3-9
8. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros J-J et al (2005) Investigation treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM and EAU recommendations. Eur Urol 48:1-4
9. The Endocrine Society: 2nd annual consensus meeting on andropause. J Clin Endocrinnol Metab. http://www.endosociety.org/, 2001.in. Jockenhovel F Male hypogonadism. 1. Auflage- Bremen, UNI-MED 2004:(188):118-123
10. Feldman HA (2002) Age trends in the levels of serum testosterone and other hormones in the middle-aged men: longitudinal results from the Massachusetts Male Aging study. J Clin Endorcrinol Metab 87:589-591
11. Isidori AM, Caprio M, Strollo F et al (1999) Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgens levels. J Clin Endrocrinol Metab 84:3673-3680
12. Khaw K, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 116:2694-2701
13. Laaksonen DE, Niskanen I, Punnonen K et al (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036-1041
14. Tsai E, Boyko EG, Leonetti DL, Fujimoto WY (2000) Low testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab disord 24:485
15. Makinen J, Jarvisalo J, Pollanen P, Perheentupa A, Irjala K, Kosekenvuo M, Makinen J, Huhtaniemi I, Raitakari OT (2005) Increased carotid atherosclerosis in Andropausal middle-aged men. J Am Coll Cardiol 45:1603-1608
16. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, Mcwhirter C (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60:762-769
17. Fung M, Bettencoast R, Barrett-Connor R (2004) Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 1405-1411
18. Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A, Balercia G, Ghiarini V, Forti G, Maggi M (2006) Psychologic correlates of metabolic syndrome and associated sexual dysfunction. Eur Urol 50:595-604
19. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone binging globulin, total testosterone and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91:843-950
20. Khan R, Buse J, Ferranni E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 28:2289-2304
21. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR (2006) Low serum testosterone and mortality in male veterans. Arch Intern Med 166:1660-1665
22. Corona G, Mannucci E, Petrone L, Schulman C, Balercia G, Fisher AD, Chiarini V, Forti G, Maggi M (2007) A comparison of NCEP -ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome associated sexual dysfunction. J Sex Med 4:789-796
23. Mäkinen JI, Perheentupa A, Irjala K, Pöllänen P, Mäkinen J, Huhtaniemi I, Raitakari OT (2008) Endogenous testosterone and serum lipids in middle-aged men. Atherosclerosis 197(2):688-693
24. Eaton CB (2005) Hyperlipidemia. Prim Care 32:1027-1055
25. Billups KL, Kaiser DR, Lelly AS, Wetterling RA, Tsai MY, Hanson N, Bank AJ (2003) Relation of C- reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res 15:231-236
26. Kolodny L (2003) Erectile dysfunction and vascular disease. What is the connection? Postrad Med 114:30-34
27. De Angelis L, Marfella MA, Sinisclchi M, Marion L, Napppo F, Giugliano F, De Lucia D, Giugliano D (2001) Erectile and endothelial dysfunction in type II diabetes. A possible link. Diabetologia 44:1155-1160
28. Billups K, Bank AJ, Padma-Nathan H, Katz S, Wiliams R (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2:40-50
29. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W (2001) A new aging males' symptoms rating scale. Ageing Male 2:105-114
30. Rosen RC (2006) Research instruments for the diagnosis and treatment of patients with erectile dysfunction. Urology 68(sup. 3A):6-16
31. Eckel HR, Grundy SM, Zimmert PZ (2005) The metabolic syndrome. Lancet 365:1415-1428
32. Tkáč I (2005) New recommendations from expert panel. Diagnosis and possibilities of influencing the metabolic syndrome. Curr Clin Praxis (Súčasná klin prax) 1:12-15
33. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Sepherd J (2003) Metabolic syndrome with and without C reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414-419
34. Lauglin GA, Barett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68-75
35. Ford ES, Abbassi F, Reaver GM (2005) Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose. Atherosclerosis 181:143-148
36. Mokaň M, Galajda P, Pridavkova D (2006) Prevalencia diabetes mellitus a metabolického syndromu na Slovensku. Diabetes a obezita 6(12):10-17